Jyoti Nautiyal, Ph.D. - Publications

Affiliations: 
2009 Cancer Biology Wayne State University, Detroit, MI, United States 
Area:
Oncology, Cell Biology

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Nautiyal J, Du J, Yu Y, Kanwar SS, Levi E, Majumdar AP. EGFR regulation of colon cancer stem-like cells during aging and in response to the colonic carcinogen dimethylhydrazine. American Journal of Physiology. Gastrointestinal and Liver Physiology. 302: G655-63. PMID 22281474 DOI: 10.1152/Ajpgi.00323.2011  0.7
2012 Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH, Majumdar AP. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis. 33: 68-76. PMID 22072622 DOI: 10.1093/Carcin/Bgr246  0.63
2011 Nautiyal J, Kanwar SS, Yu Y, Majumdar AP. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells. Journal of Molecular Signaling. 6: 7. PMID 21774804 DOI: 10.1186/1750-2187-6-7  0.721
2011 Oh PS, Patel VB, Sanders MA, Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 301: G347-55. PMID 21596996 DOI: 10.1152/Ajpgi.00403.2010  0.725
2011 Kanwar SS, Yu Y, Nautiyal J, Patel BB, Padhye S, Sarkar FH, Majumdar AP. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells. Pharmaceutical Research. 28: 827-38. PMID 21161336 DOI: 10.1007/S11095-010-0336-Y  0.729
2011 Nautiyal J, Banerjee S, Kanwar SS, Yu Y, Patel BB, Sarkar FH, Majumdar AP. Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells. International Journal of Cancer. 128: 951-61. PMID 20473900 DOI: 10.1002/Ijc.25410  0.747
2011 Kanwar SS, Yu Y, Nautiyal J, Patel BB, Padhye S, Sarkar FH, Majumdar APN. Abstract 5381: A novel strategy to eliminate chemoresistant colon cancer cells Cancer Research. 71: 5381-5381. DOI: 10.1158/1538-7445.Am2011-5381  0.649
2011 Oh P, Patel VB, Sanders MA, Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar APN. Abstract 5203: Schlafen-3 decreases cancer stem cell marker expression and autocrine/ juxtacrine signaling in FOLFOX-resistant colon cancer cells Cancer Research. 71: 5203-5203. DOI: 10.1158/1538-7445.Am2011-5203  0.611
2011 Nautiyal J, Yu Y, Kanwar SS, Patel BB, Majumdar AP. Abstract 3503: Targeting chemo-resistant colon cancer cells by the combination of dasatinib and curcumin: A novel therapeutic strategy Cancer Research. 71: 3503-3503. DOI: 10.1158/1538-7445.Am2011-3503  0.738
2011 Nautiyal J, Kanwar SS, Leavell BJ, Du J, Patel BB, Levi E, Majumdar AP. Cancer Stem Cells: Implications for Age-Related Rise in Colorectal Carcinogenesis Gastroenterology. 140: S-830. DOI: 10.1016/S0016-5085(11)63442-2  0.682
2010 Kanwar SS, Yu Y, Nautiyal J, Patel BB, Majumdar AP. The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Molecular Cancer. 9: 212. PMID 20691072 DOI: 10.1186/1476-4598-9-212  0.688
2010 Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Du J, Patel BB, Sarkar FH, Rishi AK, Mohammad RM, Majumdar AP. ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells. Molecular Cancer Therapeutics. 9: 1503-14. PMID 20515951 DOI: 10.1158/1535-7163.Mct-10-0019  0.727
2010 Nautiyal J, Kanwar SS, Majumdar AP. EGFR(s) in aging and carcinogenesis of the gastrointestinal tract. Current Protein & Peptide Science. 11: 436-50. PMID 20491625 DOI: 10.2174/138920310791824110  0.673
2010 Kanwar SS, Nautiyal J, Majumdar AP. EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new? Current Drug Targets. 11: 682-98. PMID 20298154 DOI: 10.2174/138945010791170851  0.688
2010 Nautiyal J, Yu Y, Aboukameel A, Kanwar SS, Das JK, Sarkar FH, Rishi AK, Mohammad R, Patel BB, Majumdar A. Abstract 5406: ErbB inhibitory protein [EBIP], a modified ectodomain of EGFR, synergizes with dasatinib to inhibit growth of breast cancer cells Cancer Research. 70: 5406-5406. DOI: 10.1158/1538-7445.Am10-5406  0.737
2010 Kanwar SS, Yu Y, Nautiyal J, Patel B, Majumdar APN. Abstract 4254: The Wnt/ B-catenin pathway regulates colon cancer stem cells proliferation Cancer Research. 70: 4254-4254. DOI: 10.1158/1538-7445.Am10-4254  0.548
2010 Nautiyal J, Banerjee S, Kanwar SS, Sarkar F, Majumdar AP. T1170 Curcumin Synergizes With C-SRC Inhibitor Dasatinib in Inhibiting Colon Cancer Gastroenterology. 138: S-503-S-504. DOI: 10.1016/S0016-5085(10)62325-6  0.669
2009 Yu Y, Kanwar SS, Patel BB, Nautiyal J, Sarkar FH, Majumdar AP. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX. Translational Oncology. 2: 321-8. PMID 19956394 DOI: 10.1593/Tlo.09193  0.741
2009 Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, Yu Y, Elliott AA, Levi E, Sarkar FH. Curcumin synergizes with resveratrol to inhibit colon cancer. Nutrition and Cancer. 61: 544-53. PMID 19838927 DOI: 10.1080/01635580902752262  0.746
2009 Nautiyal J, Majumder P, Patel BB, Lee FY, Majumdar AP. Src inhibitor dasatinib inhibits growth of breast cancer cells by modulating EGFR signaling. Cancer Letters. 283: 143-51. PMID 19398150 DOI: 10.1016/J.Canlet.2009.03.035  0.72
2009 Giri B, Gomes A, Sengupta R, Banerjee S, Nautiyal J, Sarkar FH, Majumdar AP. Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. Anticancer Research. 29: 395-401. PMID 19331178  0.662
2009 Nautiyal J, Yu Y, Patel B, Majumdar A. Targeting EGFRs and Src signaling with a modified ectodomain of human EGFR (EBIP) and dasatinib in breast cancer. Cancer Research. 69: 3069. DOI: 10.1158/0008-5472.Sabcs-3069  0.731
2006 Nautiyal J, Rishi AK, Majumdar AP. Emerging therapies in gastrointestinal cancers. World Journal of Gastroenterology. 12: 7440-50. PMID 17167831 DOI: 10.3748/Wjg.V12.I46.7440  0.705
2006 Rishi AK, Zhang L, Yu Y, Jiang Y, Nautiyal J, Wali A, Fontana JA, Levi E, Majumdar AP. Cell cycle- and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor. The Journal of Biological Chemistry. 281: 13188-98. PMID 16543231 DOI: 10.1074/Jbc.M512279200  0.619
Show low-probability matches.